GlaxoSmithKline : Une valse à deux temps
>Enfin une conclusion pour GSK OTC Inde - Le dénouement a enfin eu lieu ! Après de multiples rumeurs, GSK annonçait hier la sortie de Horlicks et d’autres produits en nutrition ainsi que de la fusion de son entité GSK India avec Hindustan Unilever Limited (“HULâ€). Le montant total de l’opération devrait atteindre 3.1 Md£ pour un produit net estimé par la société à 2.4 Md£.Un produit net estimé à 2,4 Md£ pour cette opération - Cette sortie n’est pas un...GlaxoSmithKline is a global healthcare company. Co.'s segments include: Pharmaceuticals; Vaccines; and Consumer Healthcare. The Pharmaceuticals segment is focused on developing new medicines in respiratory, HIV, oncology and immuno-inflammation, with discovery research exploring these and other areas. The Vaccines segment has a portfolio and pipeline of vaccines to help protect people throughout life. Co. delivers vaccines to people living in over 160 countries. The Consumer Healthcare segment develops and markets consumer-preferred brands in oral health, pain relief, respiratory, nutrition/gastro-intestinal and skin health.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.